Moving healthcare technology into the future

Cara Livernois | | Health Exec | Economics

The integration of technology into the healthcare industry has changed the way patients access. These changes have increased the need for information technology infrastructures, cybersecurity and data centers.

To fully understand where the future of healthcare technology is heading, the current landscape and trends need to be assessed. By analyzing the barriers preventing growth in the current market and where trends are leading technology, researchers, providers and government officials can identify where improvements can be made to ultimately move the industry ahead.

“However, despite the proliferation of technology in the healthcare sector, many healthcare companies aren’t providing the correct or adequate data center and IT infrastructure solutions to support their organizations’ growing technology needs,” wrote Jeremy Meyers.

Read the full story below:

Healthcare technology: Preparing for the world of tomorrow

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.